Antitumor Activity of 1,18-Octadecanedioic Acid-Paclitaxel Complexed with Human Serum Albumin
Open Access
- 18 July 2019
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 141 (30) , 11765-11769
Abstract
We describe the design, synthesis, and antitumor activity of an 18 carbon α,ω-dicarboxylic acid monoconjugated via an ester linkage to paclitaxel (PTX). This 1,18-octadecanedioic acid-PTX (ODDA-PTX) prodrug readily forms a noncovalent complex with human serum albumin (HSA). Preservation of the terminal carboxylic acid moiety on ODDA-PTX enables binding to HSA in the same manner as native long-chain fatty acids (LCFAs), within hydrophobic pockets, maintaining favorable electrostatic contacts between the ω-carboxylate of ODDA-PTX and positively charged amino acid residues of the protein. This carrier strategy for small molecule drugs is based on naturally evolved interactions between LCFAs and HSA, demonstrated here for PTX. ODDA-PTX shows differentiated pharmacokinetics, higher maximum tolerated doses and increased efficacy in vivo in multiple subcutaneous murine xenograft models of human cancer, as compared to two FDA-approved clinical formulations, Cremophor EL-formulated paclitaxel (crPTX) and Abraxane (nanoparticle albumin-bound (nab)-paclitaxel).Keywords
Funding Information
- Inamori Foundation
- Achievement Rewards for College Scientists Foundation
- Elevance Renewable Sciences, Inc.
This publication has 47 references indexed in Scilit:
- Macropinocytosis of protein is an amino acid supply route in Ras-transformed cellsNature, 2013
- Impact of albumin on drug delivery — New applications on the horizonJournal of Controlled Release, 2012
- Understanding the Warburg Effect: The Metabolic Requirements of Cell ProliferationScience, 2009
- Albumin-bound formulation of paclitaxel (Abraxane® ABI-007) in the treatment of breast cancerInternational Journal of Nanomedicine, 2009
- Improved effectiveness of nanoparticle albumin-bound (nab) paclitaxel versus polysorbate-based docetaxel in multiple xenografts as a function of HER2 and SPARC statusAnti-Cancer Drugs, 2008
- Location of High and Low Affinity Fatty Acid Binding Sites on Human Serum Albumin Revealed by NMR Drug-competition AnalysisJournal of Molecular Biology, 2006
- Potentiation of Taxol Efficacy by Discodermolide in Ovarian Carcinoma Xenograft-Bearing MiceClinical Cancer Research, 2006
- Structural Basis of the Drug-binding Specificity of Human Serum AlbuminJournal of Molecular Biology, 2005
- Multidrug resistance in cancer: role of ATP–dependent transportersNature Reviews Cancer, 2002
- Cremophor ELEuropean Journal of Cancer, 2001